Early goal-directed therapy in treatment of pediatric septic shock

Cláudio Flauzino de Oliveira1

  • 1Instituto da Criança, University of São Paulo, São Paulo, Brazil. claudio.flauzino@usp.br

Insights

Pediatric severe sepsis and septic shock cause many child deaths. Early goal-directed therapy shows promise in improving outcomes, but implementation challenges remain.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Emergency medicine

Background:

  • Sepsis is a leading cause of mortality in children under 5 globally.
  • Pediatric sepsis mortality differs from adults, primarily involving hypovolemia and low cardiac output.
  • Current treatment guidelines exist but lack robust supporting evidence.

Purpose of the Study:

  • To review recent evidence on the early management of pediatric severe sepsis and septic shock.
  • To evaluate the effectiveness and implementation of current guidelines.
  • To identify therapeutic interventions beneficial for pediatric septic shock.

Main Methods:

  • Review of recent scientific literature and evidence.
  • Analysis of retrospective studies on guideline implementation.
  • Examination of a randomized controlled trial comparing early goal-directed therapy (EGDT) to standard care.

Main Results:

  • Retrospective studies indicate positive effects of current guidelines but also highlight implementation barriers.
  • A randomized controlled trial demonstrated that EGDT is beneficial in pediatric septic shock, similar to adult findings.
  • EGDT is effective for optimizing and parameterizing treatment in pediatric septic shock.

Conclusions:

  • Early goal-directed therapy is a beneficial intervention for pediatric septic shock.
  • Despite positive results, challenges persist in simplifying and widely disseminating septic shock resuscitation protocols.
  • Further research is needed to strengthen evidence for current pediatric sepsis guidelines.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...